## ## ## ||||~Pa es| |---|---|---|---| |Trust Information|||| |Report of the Trustees|||2-6| |Independent
Auditor's|Report to|the Trustees|7-9| |Statement ofFinancial|Activities||10| |Balance Sheet|||| |Notes to the Financial|Statements||12-18| |For Trustees Information
only|||| |Detailed Income and Expenditure||Account|18| ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## |||||||||Total|Total|Total| |---|---|---|---|---|---|---|---|---|---|---| ||||||Unrestricted||Restricted|Funds||Funds| |Income from:|||Notes||Funds||Funds|2023||2022| |Donations
and legacies:||||||||||| |Donations
Charitable
activities:|||||138,233||88,000|226,233||220,277| |Fund raising events
Other trading activities:|||||32,766|||32,766||5,929| |Sale ofprints, cards
Investments||and sweatshirts|||943
8,481|||943
8,481||2,313
5,603| |Total income|||||180423||88 000|268 423||234 122| |Expenditure
on:||||||||||| |Charitable
activities
Raising fimds|||||74,518
60,440||160,085|234,604
60,440||231,686
34,929| |Total expenditure|||||134958||160085|295 043||266615| |Net income/(expenditure)||before gains||||||||| |and losses on investments|||||45,465||(72,085)|(26,620)||(32,494)| |Realised profits/(losses)
Unrealised
profits/(losses)|on investments
on investments||||(1,032)
2,165|||(1,032)
2,165||590
(2,065)| |Net income/expenditure||for the year|||46,599||(72,085)|(25,487)||(33,969)| |Transfers
between
funds|||||20,800||(20,800)|||| |Net movement
in funds|||||67,399||(92,885)|(25,487)||(33,969)| |Balances brought
forward||at 1May 2022|||290,595||187,626|478,221|6|512,191| |Balances carried forward||at30April 2023|11dt 12|t|357,993|6|94,741 t|452,735|8|478,221| ## ## ## |||||Notes||2023|2022| |---|---|---|---|---|---|---|---| |Fixed Assets|||||||| |Tangible Assets||||||570|990| |Investments||||||449,381|456,426| |||||||449,951|457,416| |Current
Assets|||||||| |Stock
Debtors
Cash at bank and in||hand||||2,316
2,905
59,777|2,884
2,691
56,018| |||||||64,997|61,592| |Creditors:|amounts|falling due within one year||10||62,214|40,787| |Net current|assets IIiiabilities)|||||2,783|20,805| |Net Assets||||||452,735|478321| |Unrestricted|Funds||||||| ||General|fund||||248,834|153,902| ||Designated||funds|||109,159|136,693| |Restricted Funds||||12||357,993
94,741|290,595
187,626| ||||||5|452,735|5 475,221| ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## |2) Direct Charitable
Expenditure
Grants for medical research to institutions
Costs ofresearch programme
Governance
costs (Note 4)|2) Direct Charitable
Expenditure
Grants for medical research to institutions
Costs ofresearch programme
Governance
costs (Note 4)||Unrestricted
Funds
47,698
18,917
7,903|Restricted
Funds
114,624
45,461|Total
2023
162,322
64,378
7,903|Total
2022
168,835
55,411
7,439| |---|---|---|---|---|---|---| ||||674,518|6160,085|$234,604|6231,686| ||Recipients ofmedical research||institutional
grants|||| ||Bournemouth
University||33,139|||| ||University ofGlasgow||70,382|||| ||Salisbury NHS Foundation|Trust|31,197|||| ||University
College London||18,838|||| ||University ofStrathclyde||8,766|||| ||||162,322|||| |3)Cost ofGenerating
Funds
Promotion
and fund raising
Cost ofprints, cards and sweatshirts
Overheads
and governance
costs (Note 4)|Unrestricted
Funds
33,260
418
26,762||Restricted
Funds||Total
2023
33,260
418
26,762||Total
2022
11,679
853
22,397| |---|---|---|---|---|---|---|---| ||60,440|8|-|f.|60,440|f,|34,929| ## |f1,250) and for o|
ther services off1,520 (2022:61,905).|au Z,|2022:| |---|---|---|---| |Direct charitable
Cost ofgenerating
Governance
costs
Governance
costs|expenditure
fimds
- medical research
- fundraising|2023
64,378
24„761
7,903
2,001|2022
55,411
21,312
7,439
1,086| |||99,043 i|85,248| ## ## |6)Tangible Fixed|Assets|||||| |---|---|---|---|---|---|---| ||||Office|||| |Cost|||E~ui ment|||Total| |At 1May 2022
Additions|||3,675|||3,675| |Disposals||||||| |At 30April 2023|||3,675|||3,675| |Depreciation||||||| |At 1 May 2022
Charge for the year|||2,685
420|||2,685
420| |On Disposals||||||| |At 30April 2023|||3,105|||3,105| |Net BookValue||||||| |At 30April 2023|||570|i||570| |At 30April 2022|||990|6||990| |7)Investments||||||| |Market value as at 30April 2022
Additions|||2023
456,426|||2022
456,756| |Disposals
Revaluation|||31,147
(26,565)||44,276
(38,804)|| |Increase/(decrease)|in cash||2,165
(13,792)|||(2,065)
(3,736)| |Market value as at 30April 2023||6|449,381|f.456,426||| |Historic cost|||366,929|i|374,343|| ## |Investments
by market value|Investments
by market value|Investments
by market value|||2023||2022| |---|---|---|---|---|---|---|---| |Charities Aid UK Equity
Royal Bank ofScotland||income Units Fund
Deposit account|B||179,454
866||173,251
861| |Quilter Cheviot Portfolio|||||146,577||150,289| |Other Bank Deposits accounts|||||122,484||132,025| |||||f|449,381|f.|456,426| |8)Stock|||||||| ||||||2023||2022| |Prints|||||152||169| |Branded products
Cards|||||1,905
259||2„495
220| |||||f|2,316|f|2,884| |9)Debtors|||||2023||2022| |Gift aid|||||||| |Prepayments
and|accrued|income|||2,905||2,691| ||||||2,905|f.|2,691| |10)Creditors: amounts||falling due within|one year||||| ||||||2023||2022| |Grants payable
Trade creditors|||||46,313
613||23,642| |Salaries|||||2,140||| |Other creditors|||||656||862| |Accruals and deferred income|||||12,492||16,283| ||||||62,214|f|40,787| |11)Unrestricted|Funds - Year ended 30April 2023||||||| |||Balance|||||Balance| |---|---|---|---|---|---|---|---| |||I May 2022|Income|Expenditure|Transfers|30|April 2023| |General fund||f153,902|179,391|(132,793)|48,334||f248,834| |Designated|for medical research|f136,693|||(27,534)||f109,159| |||290,595 f 179,391||(f132,793)|I 20,800|I|357,993| ## |11.1)U|nrestricted
Funds - Year ended|30April 2022||||| |---|---|---|---|---|---|---| |||Balance||||Balance| |||1 May 2021|Income|Expenditure|Transfers|30April 2022| |General
fund
Designated for medical research||K96,496
6154,869|126,311
-|(87,081)
-|18,176
(18,176)|6153,902
6136,693| |||k251,365|f126,311|(f87,081)||5090,595| ## ||Balance|||||Balance| |---|---|---|---|---|---|---| ||1 May 2022|Income|Expenditure|Transfers|30|April 2023| |Medical research|6187,626|88,000|(160,085)|(20,800)|I|94,741| |12.1)Restricted Funds -|Year ended 30April 2022|||||| ||Balance|||||Balance| ||1 May 2021|Income|Expenditure|Transfers|30|April 2022| |Medical research|6260,826|108,400|(181,599)|||6187,626| |13)Analysis ofnet assets|between Funds -Year ended 30April|2023||||| |Fund balances|as at30April 2023 are represented
by:|||||| ||||Unrestricted|Restricted||| ||||Funds|Funds||Total| ||Tangible fixed assets
Fixed asset investments
Net current assets / (liabilities)||570
354,640
2,783|94,741||570
449,381
2,783| ||Total net assets||f.357,993|6 94,741|K|452,735| |pril 2022 are represented
by:|||| |---|---|---|---| ||Unrestricted|Restricted|| ||Funds|Funds|Total| |Tangible fixed assets
Fixed asset investments
Net current assets / (liabilities)|990
268,800
20,805|187,626|990
456,426
20,805| |Total net assets|I290,595|I 187,626 I|478,221| ## ## ## ## |||||||Total| |---|---|---|---|---|---|---| |||||Unrestncted|Restricted|Funds| |Income from:|||Notes|Funds|Funds|2022| |Donations
and legacies:||||||| |Donations
Charitable
activities:||||111,877|108,400|220377| |Fund raising events
Other trading activities:||||5,929||5,929| |Saleofprints, cards and sweatshirts
Investments
Other income -Government
grants||||2,313
5,603||2,313
5,603| |Total income||||125,722|108,400|234,122| |Expenditure
on:||||||| |Charitable
activities
Raising funds||||50,087
34,929|181,599
-|231,686
34,929| |Total expenditure||||85,016|181,599|266,615| |Net income/(expenditure)||before gains||||| |and losses on investments||||40,706|(73,199)|(32,494)| |Realised profits/(! osses) on investments
Unrealised
profits/(losses)
on investments||||590
(2,065)||590
(2,065)| |Net income/expenditure|tbr|the year||39,230|~73,199|(33.969)| |Transfers between
funds||||||| |Net movement
in funds||||39,230|(73,199)|(33,969)| |Balances brought
forward|at|I May 2021||251365|260,826|512,191| |Balances cerned forward|at30April 2022|||290,595|8 187626|f. 478,221| ## ## ## |||||||2023|2022| |---|---|---|---|---|---|---|---| |Income|||||||| |Unrestricted|grants and|donations|||received|138,233|111,877| |Restricted
Grants &donations||||received||88,000|108,400| |Legacies|||||||| |Fundraising|and merchandise|||income||33,710|8,242| |Investment|Income|||||8,481|5,603| |Government|grants||||||| |||||||268,423|234,122| |Direct costs|||||||| |Research grants payable||snd direct costs||||162,322|168,835| |Fundraising|and merchandise|||expenditure||32,632|11,409| |Investment
management||fees||||1,046|1,123| |||||||196,000|181,367| |Overheads|||||||| |StafFSalaries||||||86,038|73,564| |Rent||||||1,400|2,100| |Travelling
snd subsistence||||||426|395| |Printing,
postage and stationery||||||487|597| |Telephone|||||||88| |Computers
and soibvare||||||1,902|1,205| |Consultancy|fees|||||624|130| |Premises expenditure|||||||| |Insurance||||||475|469| |Sundries||||||72|72| |Trustees expenses||||||2,470|1,660| |Bank charges||||||189|106| |Audit fees||||||2,688|2,400| |Professional
Depreciation|fees|||||1,182
420|1,386
480| |Finance lease|interest|||||671|595| |||||||99,043|85,248| |Investment|aine and losses||||||| |Realised gains / (losses) on investments||||||(1,032)|590| |Unrealised
gains / (losses) on investments||||||2,165|(2,065)| |||||||1,133|(1,476)| |Net Income /|(expenditure)||in|the|year|(25,487)|(33,969)|